<div>Cypionate testosterone is used in France to regulate the growth and normal development of the male sexual organs and for the maintenance of secondary sexual characteristics. These effects include: growth and maturation of the prostate, seminal vesicles, penis and scrotum; the development of hair growth in men, such as beard, pubis, chest and armpit hair; enlargement of the larynx, singing thickening of the umbilical cord and alterations in the musculature of the body and the distribution of fats. Drugs of this class also cause the retention of nitrogen, sodium, potassium and phosphorus, and a decrease in urinary excretion of calcium. Androgens have been reported to increase protein anabolism and decrease protein catabolism. Nitrogen balance is improved only when there is sufficient calorie and protein intake.</div><div><br></div><h3 style="font-family: "Open Sans", sans-serif; color: rgb(102, 102, 102);" >Dosage in France: </h3><div><br></div><div>Adulte, male 200-400 mg every 2 weeks, women in case of mamma cancer 200 to 400 mg every 2 to 4 weeks. The suggested dosage of testosterone cypionate injection varies depending on the patient's age, gender, and diagnosis. The dose in France is adjusted according to the patient's response and the appearance of side effects.</div>